Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Jul 1:13:904682.
doi: 10.3389/fimmu.2022.904682. eCollection 2022.

Risk, Incidence, and Mortality of Breast Cancer in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis

Jian Deng  1   2 , Mengsi Liu  3 , Ruoyi Xiao  3 , Jin Wang  3 , Xibei Liao  3 , Zhen Ye  3 , Zhen Sun  3
Affiliations
Meta-Analysis

Risk, Incidence, and Mortality of Breast Cancer in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis

Jian Deng et al. Front Immunol. .

Abstract

Background: Primary Sjögren's syndrome (pSS) and breast cancer are a highly prevalent autoimmune disease and malignancy, respectively, both occurring predominantly in females. Whether there is a link between these two diseases is uncertain. We conducted a systematic review and meta-analysis to investigate the risk, incidence, and mortality of breast cancer in patients with pSS.

Methods: We systematically searched Embase, PubMed, and Web of Science on January 31, 2022 to identify the study that assessed risk, incidence, or mortality of breast cancer in pSS. The fixed or random-effects models were applied to pool the effect estimates based on heterogeneity measured by Cochran's Q-test and Higgins' I2.

Results: Ten studies involving 725,805 participants and 64,836 pSS patients were included in our analysis. The pooled result showed that, overall, pSS was not associated with the risk (SIR=0.92, 95%CI: 0.66-1.29, P=0.646) and mortality (HR = 0.78, 95%CI: 0.26-2.34, P = 0.664) of breast cancer; however, when stratified by geographic region, we found that patients with pSS in Asian countries (SIR=1.32, 95%CI: 1.10-1.58, P=0.003) and Argentina (SIR=3.76, 95%CI: 1.04-9.45, P=0.019) had an elevated risk of breast cancer, while pSS in Europe was associated with a reduced risk (SIR=0.61, 95%CI: 0.51-0.73, P<0.001). The pooled result from 28,635 female pSS patients indicated that the incidence of breast cancer was 2.15 (95% CI: 1.33-3.50) per 1000 person/years.

Conclusion: This study suggests that there may be geographical differences in the association between pSS and breast cancer risk; patients with pSS in European countries are associated with a lower risk of breast cancer, while Asia and Argentina are the opposite. Future research is needed to further characterize the effect of pSS on breast cancer risk and the pathophysiological mechanisms underlying this association to unravel the complex relationship between the two.

Keywords: breast cancer; incidence; meta-analysis; mortality; primary Sjögren’s syndrome (pSS); protective factor; risk factor.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flow diagram of the study selection process.
Figure 2
Figure 2
Forest plot of the associations between primary Sjögren’s syndrome and breast cancer: (A) risk; (B) incidence; (C) mortality.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ramos-Casals M, Brito-Zerón P, Sisó-Almirall A, Bosch X. Primary Sjögren Syndrome. BMJ (2012) 344:e3821. doi: 10.1136/bmj.e3821 - DOI - PubMed
    1. Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, et al. . Epidemiology of Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis. Ann Rheum Dis (2015) 74:1983–9. doi: 10.1136/annrheumdis-2014-205375 - DOI - PubMed
    1. Alunno A, Leone MC, Giacomelli R, Gerli R, Carubbi F. Lymphoma and Lymphomagenesis in Primary Sjögren’s Syndrome. Front Med (2018) 5:102/full. doi: 10.3389/fmed.2018.00102/full - DOI - PMC - PubMed
    1. Zhang Y, Li M, Zhang L, Li Q, Yang P, Kong X, et al. . Association Between Comorbidities and Extraglandular Manifestations in Primary Sjögren’s Syndrome: A Multicenter Cross-Sectional Study. Clin Rheumatol (2020) 39:2677–88. doi: 10.1007/s10067-020-04992-x - DOI - PubMed
    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin (2021) 71:209–49. doi: 10.3322/caac.21660 - DOI - PubMed